Compound Thrombolysis Capsule is a compound Chinese patent preparation, the main ingredients of which are Panax ginseng, Astragalus membranaceus, Salvia miltiorrhiza and Radix et Rhizoma Ginseng. The main ingredients are Radix Panax Quinquefolii, Radix Astragali, Salviae Miltiorrhizae and Xuan Shen. It is used for the treatment of retinal vein occlusion with blood stasis and deficiency of qi and yin, which is characterized by decreased visual acuity or visual abnormality, fundus bruise, fatigue, dry throat, dry mouth, etc. It is also used for the treatment of stable angina pectoris with blood stasis and deficiency of qi and yin, which is characterized by tightness and pain in the chest, palpitation, panic, shortness of breath, fatigue, heartburn, dry mouth, etc. It is taken orally, the main adverse effects can be seen in patients with abnormal GPT before taking it. Usage is oral, the main adverse reactions can be seen in patients with abnormal GPT before the drug, there may be GPT increase in the process of taking the drug, the drug should be used with caution for allergic individuals, pregnant women and allergic to the drug is prohibited.